Movement Disorders · 2003 · 63 citations · 17 references
MedicineNeurosciencePharmacologyNeurochemistryNeuropharmacologySleep MedicineAmino Acid NeurochemistryCerebrospinal Fluid BiomarkersDopaminergic PharmacologyMonoamine NeurochemistryRestless Legs SyndromeAromatic L-amino Acid DecarboxylaseCerebrospinal Fluid SystemRestless Legs Syndrome PathophysiologySerotonergic MechanismsSerotonergic Neurotransmission
Cerebrospinal fluid (CSF) and blood obtained from 22 untreated or scarcely treated patients with moderate to severe restless legs syndrome (RLS; mean age, 58.6 +/- 13 years) and 11 control subjects (mean age, 56.6 +/- 12.9 years) were investigated for biogenic amines between 6:00 and 8:00 PM. We did not find any significant differences in the CSF concentrations of homovanillic acid, 3-ortho- methyl-dopa, levodopa, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, tetrahydrobiopterin, dihydrobiopterin, 5-methyltetrahydrofolate, and neopterin. In addition, serotonin in whole blood and plasma activity of aromatic amino acid decarboxylase were all normal. Our results suggest that dopaminergic and serotonergic release is not substantially affected in RLS.
17
Treatment of restless legs syndrome with gabapentin
Diego Garcı́a-Borreguero, Oscar Larrosa, Yolanda de la Llave et al. · Neurology · 2002 · 404 citations
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome
Ilonka Eisensehr, T. C. Wetter, R. Linke et al. · Neurology · 2001 · 182 citations
Positron emission tomographic studies in restless legs syndrome
Claudia Trenkwalder, Arthur S. Walters, Wayne A. Hening et al. · Movement Disorders · 1999 · 161 citations